Send to a Friend

Your name*

Your email adress*

Your friend's email address*


The Access to Insight Grants Core Faculty is pleased to announce Access to Insight – the Novo Nordisk Haemostasis Grants Initiative, which offers exciting funding opportunities specially tailored to the needs of talented haemostasis physicians and researchers.

Novo Nordisk, a healthcare company with a leading position in haemostasis management, is strongly committed to supporting haemostasis research and education.

The initiative is steered by the Access to Insight Grants Core Faculty, a group of distinguished haemostasis experts chaired by Nigel Key, MB ChB, FRCP, from the University of North Carolina School of Medicine and the Harold R. Roberts Comprehensive Hemophilia Diagnostic and Treatment Center in Chapel Hill, NC, USA.

Overview of Access to Insight funding opportunities
Basic Research Grant
  • up to € 70,000
  • 12–18 month period
  • Focus: Basic science or translational
    research relevant to the under-
    standing of the pathophysiology
    and treatment of haemostatic
Clinical Research Grant
  • up to € 70,000
  • 12 month period
  • Focus: Innovative haemostatic
    research on patient outcomes,
    quality of life, and social impacts



If you are interested in
receiving the Newsletter,
please sign up.


The Haemophilia Academy
is an independently run
training programme led
by a distinguished faculty
of haemophilia experts.